A. A. W. van Geloven
Papers
5
Total Citations
48
H-Index
3
About
A. A. W. van Geloven is a leading colorectal surgeon whose research focuses on advancing minimally invasive techniques for rectal cancer surgery, particularly total mesorectal excision (TME). Their major contributions center on comparing the oncologic safety, functional outcomes, and quality of life across laparoscopic, robot-assisted, and transanal approaches. In a landmark 2021 population-based cohort study (23 citations), van Geloven demonstrated comparable 3-year oncologic results among these techniques in experienced centers, providing crucial evidence for surgical decision-making. Their 2024 systematic review and meta-analysis (16 citations) further synthesized global data on functional outcomes and quality of life, highlighting subtle differences that impact patient recovery. Van Geloven also leads the EUREKA collaborative, a multicenter cohort study evaluating robotic rectal cancer surgery outcomes, and has developed predictive models for positive circumferential resection margins—a key risk factor for recurrence. Their work in overweight and obese populations addresses a critical gap in surgical oncology. With over 48 citations across their most-cited papers, van Geloven’s research directly informs clinical guidelines and surgical training, positioning them as a key voice in the evolution of rectal cancer care toward safer, more patient-centered approaches.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5